featured
AASLD 2018: Regular Aspirin Use Is Linked to a Dose-Dependent Reduction in Risk of Hepatocellular Carcinoma
Risk reduction is apparent after at least 5 years of aspirin use.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.